Editor's note: Read the latest on how the coronavirus is rattling the markets and what you can do to navigate it.
Capture opportunities in biotechnology
Learn about the Morningstar Exponential Technologies Index here
Editor's note: Read the latest on how the coronavirus is rattling the markets and what you can do to navigate it.
Learn about the Morningstar Exponential Technologies Index here
You need a few things to go right to be successful, if the fund survives
An impressive performance worth considering
Better business and resilience come with sophisticated innovations: Sustainalytics
CPMS's Phil Dabo finds superior risk-adjusted returns alongside strong cash flow characteristics
Demand for COVID-19 vaccines has seen interest in pharma stocks soar, but Morningstar analysts th...
Eventually, ETFs will be the industry standard
The price of the radioactive metal rose last year - what's behind the recent optimism? We ask sec...
CPMS's Phil Dabo finds superior risk-adjusted returns alongside strong cash flow characteristics
Demand for COVID-19 vaccines has seen interest in pharma stocks soar, but Morningstar analysts th...
How can you get in the best financial shape at the start of the year?
Security Name | Price | Change (%) | Morningstar Rating |
---|---|---|---|
AbbVie Inc | 110.86 USD | -0.36 | ![]() |
Pfizer Inc | 36.55 USD | 0.19 | ![]() |
Damien Conover, CFA Damien Conover, CFA, is director of healthcare equity research and equity strategy for Morningstar.